PPT-Trial Design Evolocumab SC
140 mg Q2W or 420 mg QM Placebo SC Q2W or QM LDLC 70 mg dL or nonHDLC 100 mg dL Followup Q 12 weeks Screening Lipid Stabilization and Placebo Runin High or moderate
Download Presentation
Download Note : "Trial Design Evolocumab SC" is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Transcript not available.